Screening for Hearing Loss in Older Adults: U.S. Preventive Services Task Force Recommendation Statement
Update of the 2003 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for dementia.
The USPSTF reviewed the evidence on the benefits, harms, and sensitivity and specificity of screening instruments for cognitive impairment in older adults and the benefits and harms of commonly used treatment and management options for older adults with mild cognitive impairment or early dementia and their caregivers.
This recommendation applies to universal screening with formal screening instruments in community-dwelling adults in the general primary care population who are older than 65 years and have no signs or symptoms of cognitive impairment.
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for cognitive impairment. (I statement).
Available from: Liliane Desgualdo Pereira
- "Recently, some initiatives and a number of studies have promoted the definition and implementation of effective programs of hearing screening, prevention, surveillance, and care for adults and older adults, particularly in Europe and in the United States [10, 14–16], although the value and BioMed Research International need for community hearing screening in adults are still controversial. As reported by the US Preventive Services Task Force reports, current evidence is insufficient to assess the balance of benefits and harms of screening in adults without symptoms of hearing loss, and additional research is needed to understand the effects of screening for hearing loss compared with no screening on health outcomes  . Nevertheless, the research reported by Yueh et al. in 2010  did indeed suggest that hearing screening can be a catalyst in moving individuals from just a hearing loss to actually doing something about it. "
[Show abstract] [Hide abstract]
ABSTRACT: This paper describes the development of a speech-in-noise test for hearing screening and surveillance in Brazilian Portuguese based on the evaluation of suprathreshold acuity performances. The SUN test (Speech Understanding in Noise) consists of a list of intervocalic consonants in noise presented in a multiple-choice paradigm by means of a touch screen. The test provides one out of three possible results: "a hearing check is recommended" (red light), "a hearing check would be advisable" (yellow light), and "no hearing difficulties" (green light) (Paglialonga et al., Comput. Biol. Med. 2014). This novel test was developed in a population of 30 normal hearing young adults and 101 adults with varying degrees of hearing impairment and handicap, including normal hearing. The test had 84% sensitivity and 76% specificity compared to conventional pure-tone screening and 83% sensitivity and 86% specificity to detect disabling hearing impairment. The test outcomes were in line with the degree of self-perceived hearing handicap. The results found here paralleled those reported in the literature for the SUN test and for conventional speech-in-noise measures. This study showed that the proposed test might be a viable method to identify individuals with hearing problems to be referred to further audiological assessment and intervention.
BioMed Research International 08/2014; 2014:652838. DOI:10.1155/2014/652838 · 2.71 Impact Factor
Available from: Kei Nakajima
- "In this context, we focused on subclinical objective hearing loss, which is often undetected and left untreated  , and investigated the lifestyles of individuals with subclinical hearing loss and the etiology of subclinical hearing loss. Because frequency of 500 to 4000 Hz is important range for speech processing , we determined whether hearing function at representative high (4000 Hz) and low (1000 Hz) frequencies, which are usually examined in a hearing screening test in Japan   , was associated with lifestyle factors, including sleep duration per night and cardiometabolic risk factors, in a cross-sectional study of Japanese general population. Because hearing loss has been shown to be associated with cardiometabolic risk factors, such as diabetes and smoking      , we considered these factors as relevant confounding factors and also examined the associations between hearing loss and these cardiometabolic risk factors. "
[Show abstract] [Hide abstract]
ABSTRACT: Hearing loss leads to impaired social functioning and quality of life. Hearing loss is also associated with sleeping disorders and cardiometabolic risk factors. Here, we determined whether subclinical hearing loss is associated with sleep duration and cardiometabolic risk factors in a cross-sectional and longitudinal study of healthy Japanese general population. 48,091 men and women aged 20-79 years who underwent medical checkups were included in a cross-sectional study, and 6,674 were included in an 8-year longitudinal study. The prevalence of audiometrically determined hearing loss (>25 dB) at 4000 and 1000 Hz increased significantly with increasing sleep duration in any age strata. Logistic regression analysis showed that compared with reference sleep duration (6 h) longer sleep duration (≥8 h) was significantly associated with hearing loss, even after adjusting for potential confounding factors. Simultaneously, hearing loss was significantly associated with male sex, diabetes, and no habitual exercise. In the longitudinal study, the risk of longer sleep duration (≥8 h) after 8 years was significantly greater in subjects with hearing loss at 4000 Hz at baseline. In conclusion, current results suggest a potential association of subclinical hearing loss with longer sleep duration and cardiometabolic risk factors in a Japanese general population.
International Journal of Otolaryngology 08/2014; 2014:218218. DOI:10.1155/2014/218218
09/2012; 16(5):868-9. DOI:10.4103/2230-8210.100710
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.